Health Care Equipment & Supplies (49) | License Agreements (49)
Browse by Company
-
AIT Therapeutics, Inc. (1)
-
Akers Biosciences, Inc. (1)
-
AxoGen, Inc. (2)
-
BioSig Technologies, Inc. (3)
-
Bioventus Inc. (4)
-
Conformis Inc (1)
-
Dare Bioscience, Inc. (3)
-
DELCATH SYSTEMS, INC. (1)
-
EKSO BIONICS HOLDINGS, INC. (1)
-
Envista Holdings Corp (2)
-
GUIDED THERAPEUTICS INC (1)
-
Heska Corporation (1)
-
Hologic (1)
-
LeMaitre Vascular, Inc. (1)
-
Nemaura Medical Inc. (2)
-
NEUROONE MEDICAL TECHNOLOGIES Corp (2)
-
OZOP SURGICAL CORP. (1)
-
PetVivo Holdings, Inc. (1)
-
ReWalk Robotics Ltd. (1)
-
ROCKWELL MEDICAL, INC. (3)
-
SANUWAVE Health, Inc. (1)
-
SECOND SIGHT MEDICAL PRODUCTS INC (1)
-
Silk Road Medical Inc (2)
-
Sintx Technologies, Inc. (1)
-
TANDEM DIABETES CARE INC (1)
-
TearLab Corp (1)
-
TELA Bio, Inc. (5)
-
WOUND MANAGEMENT TECHNOLOGIES, INC. (4)
Recent Contracts
-
Patent License Agreement, dated February 25, 2021, between the Company and O2 Design, Inc
(Sintx Technologies, Inc., Filed With SEC on May 13, 2021)
-
Seventh Amendment to License and Services Agreement, dated as of February 22, 2021, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissues Services)
(AxoGen, Inc., Filed With SEC on February 26, 2021)
-
License Agreement, dated May 16, 2016, between the Company and the President and Fellows of Harvard College
(ReWalk Robotics Ltd., Filed With SEC on February 18, 2021)
-
Amendment No. 2 to Exclusive License, Supply and Distribution Agreement, dated as of December 31, 2020, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC
(Bioventus Inc., Filed With SEC on February 4, 2021)
-
Amended and Restated License Agreement, dated as of December 9, 2016, by and between Bioventus LLC, Q-Med AB and Nestl Skin Health S.A
(Bioventus Inc., Filed With SEC on January 20, 2021)
-
Exclusive License, Supply and Distribution Agreement, dated as of February 9, 2016, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC
(Bioventus Inc., Filed With SEC on January 20, 2021)
-
Amendment No. 1 to Exclusive License, Supply and Distribution Agreement, dated as of December 31, 2018, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC
(Bioventus Inc., Filed With SEC on January 20, 2021)
-
Form of Exclusive License Agreement, by and between Second Sight, Pixium, and Spinco
(SECOND SIGHT MEDICAL PRODUCTS INC, Filed With SEC on January 6, 2021)
-
Amendment No. 1 to Exclusive License Agreement dated July 7, 2019 with Rochal Industries, LLC
(WOUND MANAGEMENT TECHNOLOGIES, INC., Filed With SEC on November 13, 2020)
-
Amendment No. 7 to Supply and License Agreement between Registrant and Intervet Inc., d.b.a. Merck Animal Health, effective as of September 18, 2020
(Heska Corporation, Filed With SEC on November 5, 2020)
